220 related articles for article (PubMed ID: 19650159)
1. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
Fujita K; Nozaki Y; Wada K; Yoneda M; Fujimoto Y; Fujitake M; Endo H; Takahashi H; Inamori M; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
Hepatology; 2009 Sep; 50(3):772-80. PubMed ID: 19650159
[TBL] [Abstract][Full Text] [Related]
2. Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.
Fujita K; Imajo K; Shinohara Y; Nozaki Y; Wada K; Yoneda M; Endo H; Takahashi H; Abe Y; Inamori M; Shimamura T; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
J Pharmacol Sci; 2011; 115(3):270-3. PubMed ID: 21350309
[TBL] [Abstract][Full Text] [Related]
3. A lipidomic analysis of nonalcoholic fatty liver disease.
Puri P; Baillie RA; Wiest MM; Mirshahi F; Choudhury J; Cheung O; Sargeant C; Contos MJ; Sanyal AJ
Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
[TBL] [Abstract][Full Text] [Related]
5. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
[TBL] [Abstract][Full Text] [Related]
6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?
Gambino R; Cassader M; Pagano G; Durazzo M; Musso G
Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986
[TBL] [Abstract][Full Text] [Related]
8. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis.
Zhu L; Baker SS; Liu W; Tao MH; Patel R; Nowak NJ; Baker RD
Metabolism; 2011 Jul; 60(7):1001-11. PubMed ID: 21075404
[TBL] [Abstract][Full Text] [Related]
9. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
Nomura K; Yamanouchi T
J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
[TBL] [Abstract][Full Text] [Related]
10. Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.
Fujii Y; Nouso K; Matsushita H; Kariyama K; Sakurai T; Takahashi Y; Chiba H; Hui SP; Ito Y; Ohta M; Okada H
J Appl Lab Med; 2020 Nov; 5(6):1206-1215. PubMed ID: 32674154
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
[TBL] [Abstract][Full Text] [Related]
12. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.
Singh H; Pollock R; Uhanova J; Kryger M; Hawkins K; Minuk GY
Dig Dis Sci; 2005 Dec; 50(12):2338-43. PubMed ID: 16416185
[TBL] [Abstract][Full Text] [Related]
14. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.
Puri P; Mirshahi F; Cheung O; Natarajan R; Maher JW; Kellum JM; Sanyal AJ
Gastroenterology; 2008 Feb; 134(2):568-76. PubMed ID: 18082745
[TBL] [Abstract][Full Text] [Related]
15. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
Cano A; Buqué X; Martínez-Uña M; Aurrekoetxea I; Menor A; García-Rodríguez JL; Lu SC; Martínez-Chantar ML; Mato JM; Ochoa B; Aspichueta P
Hepatology; 2011 Dec; 54(6):1975-86. PubMed ID: 21837751
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
Musso G; Gambino R; Cassader M
J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
[TBL] [Abstract][Full Text] [Related]
17. The plasma lipidomic signature of nonalcoholic steatohepatitis.
Puri P; Wiest MM; Cheung O; Mirshahi F; Sargeant C; Min HK; Contos MJ; Sterling RK; Fuchs M; Zhou H; Watkins SM; Sanyal AJ
Hepatology; 2009 Dec; 50(6):1827-38. PubMed ID: 19937697
[TBL] [Abstract][Full Text] [Related]
18. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.
Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M
Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein synthesis in nonalcoholic steatohepatitis.
Charlton M; Sreekumar R; Rasmussen D; Lindor K; Nair KS
Hepatology; 2002 Apr; 35(4):898-904. PubMed ID: 11915037
[TBL] [Abstract][Full Text] [Related]
20. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y
PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
